Clinical and Translational Science Center

临床和转化科学中心

• 批准号: 10213868
• 负责人: JULIANNE L IMPERATO-MCGINLEY
• 金额: $ 769.11万
• 依托单位: WEILL MEDICAL COLL OF CORNELL UNIV
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-09-05 至 2022-07-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10213868
• 关键词: Accountability; Address; Animals; Area; Basic Science; Biomedical Engineering; Center for Translational Science Activities; Characteristics; Child; Clinical; Clinical Management; Clinical Research; Clinical Sciences; Clinical Trials; Collaborations; Complex; Development; Education; Ensure; Environment; Ethics; Evaluation; Fostering; Foundations; Home; Human; Individual; Industry Standard; Institutes; Institution; Lead; Leadership; Medical Research; Medical center; Medicine; Memorial Sloan-Kettering Cancer Center; Methods; Minority-Serving Institution; Needs Assessment; Operative Surgical Procedures; Patient Care; Performance; Pilot Projects; Positioning Attribute; Process; Recommendation; Rehabilitation therapy; Reporting; Research; Research Institute; Research Training; Resources; School Nursing; Schools; Special Hospitals; Standardization; Structure; System; Training; Training and Education; Translational Research; Universities; Veterinary Medicine; base; cohesion; college; community organizations; design; experimental study; fundamental research; improved; innovation; member; nanobiotechnology; programs; quality assurance; recruit; response; synergism; tool; urban public health; urban school

A. ADMINISTRATIVE CORE PROJECT SUMMARY/ABSTRACT During the past ten years the Weill Cornell Clinical and Translational Science Center (CTSC) has established an inclusive, strong and highly effective governance structure incorporating our partners as active members. As lead institution, Weill Cornell Medicine (WCM) serves as an academic home through which essential resources, technological tools and education programs can be efficiently shared and managed. The partner institutions comprising the CTSC are also neighbors located on York Avenue “The Translational Research Avenue”. Within the immediate area are: Memorial Sloan Kettering Cancer Center (MSK); Hospital for Special Surgery (HSS); Hunter College (HC), School of Nursing (HCSON) and its Center for Translational and Basic Research (CTBR)/Research Center for Minority Institutions (RCMI), School of Urban Public Health; and the Animal Medical Center. In addition to this partnership, the CTSC has extensive ties to both Cornell University, Ithaca (CU) (particularly with the Nanobiotechnology Center, the Schools of Bioengineering and Veterinary Medicine), The McGovern Center for Venture Development and to the Burke Medical Research Institute for Rehabilitation, White Plains NY. The resulting cluster of institutions forms a unique and cohesive biomedical complex fulfilling the NCATS roadmap initiative of breaking-down institutional and disciplinary silos to accelerate translational research. Individually, the partner institutions are superb centers of intellectual and academic excellence. Their integration into the CTSC harnesses their distinctive characteristics, hastening clinical and translational research breakthroughs for improved patient care. The CTSC Administrative Core is tightly integrated with Evaluation and Continuous Improvement and Quality and Efficiency. Administration oversees the management of the CTSC, including introduction of the Balanced Scorecard approach. Evaluation and Tracking accomplishes the assessment of translational research and training innovations, introducing in this cycle the integration of the Results Based Accountability framework central to CTSA Common metrics, and the idea of targeted micro- experiments that can lead to multi-hub pilot studies and eventual impact on the CTSA network and the field. The Quality and Efficiency section enhances trial efficiency and recruitment through the introduction of a CTSC Performance Management Team. The Performance Management Team (PMT) will be the mechanism by which the CTSC improves research process performance. It will incorporate both the Balanced Scorecard approach used by the AC and the Results-Based Accountability approach that is the foundation of the CTSA Common Metrics effort.

A.行政核心 项目摘要/摘要 在过去的十年里，威尔康奈尔临床和翻译科学中心(CTSC)建立了 一个包容、强大和高度有效的治理结构，将我们的合作伙伴纳入为积极成员。AS 领导机构威尔·康奈尔医学(WCM)是一个学术之家，通过它， 技术工具和教育项目可以有效地共享和管理。合作机构 组成CTSC的还有位于约克大道“翻译研究大道”的邻居。在 最近的区域是：纪念斯隆·凯特琳癌症中心(MSK)、特殊外科医院(HSS)； 亨特学院(HC)、护理学院(HCSON)及其翻译和基础研究中心 城市公共卫生学院(CTBR)/少数民族机构研究中心(RCMI)；以及动物医学 中心。除了这一伙伴关系，CTSC还与康奈尔大学、伊萨卡大学(CU) (特别是与纳米生物技术中心、生物工程学院和兽医学院合作) 麦戈文风险发展中心和伯克医学康复研究所，怀特 纽约州普莱恩斯。由此产生的机构集群形成了一个独特的、具有凝聚力的生物医学综合体，实现了 NCATS打破机构和学科孤岛以加速翻译的路线图计划 研究。就个人而言，合作机构是卓越的智力和学术卓越中心。他们的 与CTSC的整合利用了它们的独特特性，加速了临床和转译研究 在改善患者护理方面取得突破。CTSC管理核心与评估紧密结合 不断改进和提高质量和效率。行政当局监督管理 CTSC，包括采用平衡计分卡方法。评估和跟踪实现了 评估翻译研究和培训创新，在本周期中引入 以结果为基础的问责框架是CTSA通用指标的核心，以及有针对性的微观 可导致多集线器试点研究并最终对CTSA网络和现场产生影响的实验。这个 质量和效率科通过引入CTSC来提高审判效率和征聘 绩效管理团队。绩效管理团队(PMT)将成为 CTSC提高了研究过程的绩效。它将结合平衡计分卡方法 由审计委员会和成果问责制使用，这是CTSA共同的基础 衡量标准的努力。